Cathie Wood isn’t backing off Tesla; she’s buying in deeper. The Ark Invest founder just added another 115,380 Tesla shares on July 15 across two of her flagship funds. The buy totaled roughly $36 ...

Guardant is another Cathie Wood stock that stands to grow into the huge market for preventative cancer screening. The company uses proprietary blood-based tests and advanced analytics to manage ...

At least that's what Cathie Wood's recent purchases suggest. ... Medicare and other end payers are generally keen to pay $2,841 for the blood-based test because it's still cheaper than the ...

At that time, Cathie Wood's portfolio may reap the rewards in a big way -- and if you follow her into this innovative company now, your portfolio may, too. Should you invest $1,000 in Moderna ...

Cathie Wood, CEO of ARK Invest, is doubling down on biologics, seeing unprecedented potential at the intersection of artificial intelligence, genetic sequencing, and gene editing technologies.

Cathie Wood, the star fund manager and chief executive of ARK Invest, in a Tuesday monthly market update says that the used car market is where she is expecting possible losses after a surge in ...

Cathie Wood is having another rough year. ... Shield is a simple blood test. Guardant products completed 202,800 clinical or biopharmaceutical tests last year, ...